Ashley Gallagher

This schedule arrives at a time of unprecedented friction between leading medical societies and federal health agencies.

This decision marks a milestone in clinical pharmacy as it targets the underlying autoimmune destruction of pancreatic beta cells.

A study examining naloxone sales found that retail OTC sales have been surprisingly limited despite improvements in access.

Community pharmacies redesign workflows to address insurance barriers and deliver safer, gender-affirming care.

FDA clears first generic Xofluza tablet, bringing affordable single-dose flu treatment and prevention.

Community pharmacists help prevent chronic wounds with early triage, modern dressing guidance, and diabetic foot care.

The ACTIV-6 trial suggests early metformin may halve clinician-diagnosed long COVID risk, offering a low-cost option pharmacists can apply safely.

FDA advisors back Moderna’s mRNA flu shot for older adults, hinting at a potential egg-free option for 2026–2027.

Pharmacists help spot nonresponders, navigate accurate testing, and speed diagnosis.

Fexofenadine 180 mg once daily offers 24-hour seasonal allergy control with minimal CNS penetration, but should be avoided with fruit juices and aluminum/magnesium antacids.